Brigitta Mester

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme

Martin K. Hunn, Evelyn Bauer, Catherine Wood et al. · Journal of Neuro-Oncology · 2014 · 61 citations

Vaccination, Neuro-oncology, Dendritic Cell Vaccination +13

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

Olivier Gasser, Katrina Sharples, Catherine Barrow et al. · Cancer Immunology Immunotherapy · 2017 · 56 citations · Full text

Vaccination, Cancer Immunosurveillance, High-risk Melanoma Patients +15

Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE)

P J George, Nathaniel Dasyam, Giulia Giunti et al. · BMJ Open · 2020 · 49 citations · Full text

Oocyte expression, secretion and somatic cell interaction of mouse bone morphogenetic protein 15 during the peri-ovulatory period

Brigitta Mester, Lesley J. Ritter, Janet L. Pitman et al. · Reproduction Fertility and Development · 2014 · 31 citations

Oocyte, Fertility, Female Reproductive Function +27

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

Nathaniel Dasyam, Katrina Sharples, Catherine Barrow et al. · Cancer Immunology Immunotherapy · 2023 · 18 citations · Full text